Delivery Order SPE2DB22D1017-SPE2DB25FYRER
- Not listed
- The Defense Logistics Agency awarded a $1,353.29 delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count) on August 21, 2025, with completion expected by August 22, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a single pharmaceutical supply transaction executed under AmerisourceBergen's larger federal contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,556.63 for Carvedilol ER 40 mg capsules (30-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and specifies performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units) with a ceiling value of $3,309.42 under firm fixed price terms. The order is scheduled for completion by September 19, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued as a child order under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a contract ceiling value of $2,339.36. This is a firm fixed-price delivery order with no set-aside designation, executed through open competition. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract has an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a contract ceiling value of $10,871.08. This firm fixed-price delivery order, which is scheduled for completion by July 21, 2025, represents a non-competitive, non-set-aside award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) under a firm fixed-price contract valued at $15,959.88. The award, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count packaging) with a ceiling value of $10,683.54. This is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on September 15, 2025, for Carvedilol ER 20 mg capsules (30-count packaging) with a ceiling value of $6,836.77. This is a firm fixed-price delivery order with an ultimate completion date of September 16, 2025, and no set-aside designation was used in the award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units) with a ceiling value of $1,606.87. This is a firm fixed-price delivery order issued under a non-competitive set-aside basis. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count units) with a ceiling value of $12,029.39. This firm fixed-price delivery order, which is not set-aside, represents a competitive award through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYRERDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count packages) with a ceiling value of $1,401.21. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the open market. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. As a child contract action, this delivery order draws from AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a prime vendor agreement valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company's portfolio with the federal government encompasses an extensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The DLA Troop Support Medical prime vendor contract enables the company to supply pharmaceutical products globally to support military healthcare programs, with anticipated customers including the Defense Health Agency and U.S. Coast Guard. The current delivery order for Carvedilol ER represents a routine pharmaceutical replenishment within this comprehensive federal supply relationship.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/18/25 |